JADPRO Live 2017 Educational Activities
These educational activities are based on presentations from JADPRO Live at APSHO 2017. Access the full-length video presentation, the slide deck, transcript, and the entire lecture as a podcast. Click on any of the video presentations below to get started!
This activity is supported by independent educational grants from Merck Sharp & Dohme Corp, Novartis Pharmaceuticals Corporation, Puma Biotechnology, Takeda Oncology.
New Drug Updates in Hematologic Malignancies: CAR T Cells, Targeted Therapeutics, and Other Agents
Get an update on the fast-changing world of therapies for hematologic malignancies. With the constantly growing list of new drugs and indications, as well as the introduction of cutting-edge CAR T-cell therapy for the treatment of hematologic malignancies, it’s important that advanced practitioners stay up to date on the latest advances to be able to adequately diagnose, treat, and help patients navigate potential side effects.
Posted: January 22, 2018 / Expires: January 22, 2019
This certified activity has expired but you may watch the video without claiming credit.